United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $43.34 Million Holdings in Intuitive Surgical, Inc. $ISRG

by · The Cerbat Gem

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 4.0% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,751 shares of the medical equipment provider’s stock after selling 3,339 shares during the period. Intuitive Surgical accounts for approximately 1.7% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s investment portfolio, making the stock its 22nd biggest position. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in Intuitive Surgical were worth $43,337,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Tobam increased its stake in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. TD Capital Management LLC increased its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. 1248 Management LLC bought a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Finally, Bank of Jackson Hole Trust boosted its stake in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 31 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $574.23 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock’s fifty day moving average price is $500.48 and its two-hundred day moving average price is $504.89. The company has a market cap of $205.85 billion, a PE ratio of 75.96, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.84 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 116,164 shares of company stock worth $61,916,172 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on ISRG. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 price target on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Rothschild & Co Redburn increased their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $608.92.

View Our Latest Analysis on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).